Autophagy as a pathogenic mechanism and drug target in lymphoproliferative disorders
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Autophagy as a pathogenic mechanism and drug target in lymphoproliferative disorders
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume 28, Issue 2, Pages 524-535
Publisher
FASEB
Online
2013-11-07
DOI
10.1096/fj.13-235655
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Decreased expression of autophagy-related proteins in malignant epithelial ovarian cancer
- (2014) Yang Shen et al. Autophagy
- The autophagy geneATG5plays an essential role in B lymphocyte development
- (2014) Brian C. Miller et al. Autophagy
- A dual role of p53 in the control of autophagy
- (2014) Ezgi Tasdemir et al. Autophagy
- Role of microRNA in the pathogenesis of malignant lymphoma
- (2013) Hiroyuki Tagawa et al. CANCER SCIENCE
- Gender Disparity in Pediatric Diseases
- (2013) D. Del Principe et al. CURRENT MOLECULAR MEDICINE
- Temsirolimus in the treatment of mantle cell lymphoma
- (2013) Krimo Bouabdallah et al. CURRENT OPINION IN ONCOLOGY
- Targeting oncogenic and epigenetic survival pathways in lymphoma
- (2013) Lori A. Leslie et al. LEUKEMIA & LYMPHOMA
- Plasma cells require autophagy for sustainable immunoglobulin production
- (2013) Niccolò Pengo et al. NATURE IMMUNOLOGY
- Constitutive localization of DR4 in lipid rafts is mandatory for TRAIL-induced apoptosis in B-cell hematologic malignancies
- (2013) M Marconi et al. Cell Death & Disease
- The TP53 tumor suppressor and autophagy in malignant lymphoma
- (2012) Zijun Y. Xu-Monette et al. Autophagy
- Autophagy prolongs survival after NFκB inhibition in B-cell lymphomas
- (2012) Thomas G. Sommermann et al. Autophagy
- Autophagy controls everolimus (RAD001) activity in mantle cell lymphoma
- (2012) Laia Rosich et al. Autophagy
- Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies
- (2012) Z. Y. Xu-Monette et al. BLOOD
- Phase II study of sorafenib in patients with relapsed or refractory lymphoma
- (2012) Anna Guidetti et al. BRITISH JOURNAL OF HAEMATOLOGY
- miRNA-130a Targets ATG2B and DICER1 to Inhibit Autophagy and Trigger Killing of Chronic Lymphocytic Leukemia Cells
- (2012) V. Kovaleva et al. CANCER RESEARCH
- Current treatment strategies in Hodgkin lymphomas
- (2012) Amanda Copeland et al. CURRENT OPINION IN ONCOLOGY
- T lymphocytes from patients with systemic lupus erythematosus are resistant to induction of autophagy
- (2012) Cristiano Alessandri et al. FASEB JOURNAL
- Normal and cancer cell metabolism: lymphocytes and lymphoma
- (2012) Brian J. Altman et al. FEBS Journal
- Metabolism and autophagy in the immune system: immunometabolism comes of age
- (2012) Jeffrey C. Rathmell IMMUNOLOGICAL REVIEWS
- The contribution of autophagy to lymphocyte survival and homeostasis
- (2012) Ian X. McLeod et al. IMMUNOLOGICAL REVIEWS
- Hodgkin lymphoma
- (2012) Ralf Küppers et al. JOURNAL OF CLINICAL INVESTIGATION
- Non-Hodgkin lymphoma
- (2012) Kate R Shankland et al. LANCET
- Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy
- (2012) W-Y Shi et al. Cell Death & Disease
- The Role of Atg Proteins in Autophagosome Formation
- (2011) Noboru Mizushima et al. Annual Review of Cell and Developmental Biology
- PI3K inhibitor, GS-1101 (CAL-101), attenuates pathway signaling, induces apoptosis, and overcomes signals from the microenvironment in cellular models of Hodgkin lymphoma
- (2011) S. A. Meadows et al. BLOOD
- Mitochondrial dysfunction in ataxia-telangiectasia
- (2011) Y. A. Valentin-Vega et al. BLOOD
- The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia
- (2011) J. Hoellenriegel et al. BLOOD
- Cell death by autophagy: facts and apparent artefacts
- (2011) D Denton et al. CELL DEATH AND DIFFERENTIATION
- Autophagy promotes T-cell survival through degradation of proteins of the cell death machinery
- (2011) J R Kovacs et al. CELL DEATH AND DIFFERENTIATION
- mTOR Signaling and Metabolic Regulation of T Cells: New Potential Therapeutic Targets in Autoimmune Diseases
- (2011) Marina Pierdominici et al. CURRENT PHARMACEUTICAL DESIGN
- Targeting the mTOR kinase domain: the second generation of mTOR inhibitors
- (2011) Yan-Jie Zhang et al. DRUG DISCOVERY TODAY
- Direct activation of mTOR in B lymphocytes confers impairment in B-cell maturation andloss of marginal zone B cells
- (2011) Sandrine Benhamron et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Beclin 1 expression predicts favorable clinical outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP
- (2011) Jia-Jia Huang et al. HUMAN PATHOLOGY
- On the role of autophagy in human diseases: a gender perspective
- (2011) Pasquale Lista et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A Role for Autophagic Protein Beclin 1 Early in Lymphocyte Development
- (2011) I. Arsov et al. JOURNAL OF IMMUNOLOGY
- Temporal Regulation of Intracellular Organelle Homeostasis in T Lymphocytes by Autophagy
- (2011) W. Jia et al. JOURNAL OF IMMUNOLOGY
- Regulation of autophagy in hematological malignancies: role of reactive oxygen species
- (2011) Ganchimeg Ishdorj et al. LEUKEMIA & LYMPHOMA
- A phase 2 study of vorinostat for treatment of relapsed or refractory Hodgkin lymphoma: Southwest Oncology Group Study S0517
- (2011) Mark H. Kirschbaum et al. LEUKEMIA & LYMPHOMA
- The Role of Autophagy in Cancer: Therapeutic Implications
- (2011) Z. J. Yang et al. MOLECULAR CANCER THERAPEUTICS
- Autophagy as a target for anticancer therapy
- (2011) Filip Janku et al. Nature Reviews Clinical Oncology
- Utility of mTOR Inhibition in Hematologic Malignancies
- (2011) A. Younes et al. ONCOLOGIST
- Beclin 1 expression: A predictor of prognosis in patients with extranodal natural killer T-cell lymphoma, nasal type
- (2010) Jia-Jia Huang et al. Autophagy
- CAL-101, a p110 selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability
- (2010) B. J. Lannutti et al. BLOOD
- Phosphatidylinositol 3-kinase- inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals
- (2010) S. E. M. Herman et al. BLOOD
- Beyond Rapalog Therapy: Preclinical Pharmacology and Antitumor Activity of WYE-125132, an ATP-Competitive and Specific Inhibitor of mTORC1 and mTORC2
- (2010) K. Yu et al. CANCER RESEARCH
- Targeting autophagy to fight hematopoietic malignancies
- (2010) Alexandre Puissant et al. CELL CYCLE
- The Beclin 1 interactome
- (2010) Congcong He et al. CURRENT OPINION IN CELL BIOLOGY
- The Mammalian Target of Rapamycin: Linking T Cell Differentiation, Function, and Metabolism
- (2010) Jonathan D. Powell et al. IMMUNITY
- Macroautophagy Regulates Energy Metabolism during Effector T Cell Activation
- (2010) V. M. Hubbard et al. JOURNAL OF IMMUNOLOGY
- p53 and autophagy contribute to dasatinib resistance in primary CLL lymphocytes
- (2010) Lilian Amrein et al. LEUKEMIA RESEARCH
- Autophagy-active beclin-1 correlates with favourable clinical outcome in non-Hodgkin lymphomas
- (2010) Giuseppina Nicotra et al. MODERN PATHOLOGY
- Network organization of the human autophagy system
- (2010) Christian Behrends et al. NATURE
- Eaten alive: a history of macroautophagy
- (2010) Zhifen Yang et al. NATURE CELL BIOLOGY
- Cell death in hematological tumors
- (2009) Simone Fulda APOPTOSIS
- Identification ofAtg5-dependent transcriptional changes and increases in mitochondrial mass inAtg5-deficient T lymphocytes
- (2009) Linda M. Stephenson et al. Autophagy
- In search of an “autophagomometer”
- (2009) David C. Rubinsztein et al. Autophagy
- The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy
- (2009) L. Ellis et al. BLOOD
- Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies
- (2009) David T. Teachey et al. BRITISH JOURNAL OF HAEMATOLOGY
- AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity
- (2009) C. M. Chresta et al. CANCER RESEARCH
- miR-19 is a key oncogenic component of mir-17-92
- (2009) V. Olive et al. GENES & DEVELOPMENT
- Autophagy Is Essential for Mitochondrial Clearance in Mature T Lymphocytes
- (2009) H. H. Pua et al. JOURNAL OF IMMUNOLOGY
- Targeted therapy in T-cell malignancies: dysregulation of the cellular signaling pathways
- (2009) W-L Zhao LEUKEMIA
- Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies
- (2009) J Iqbal et al. LEUKEMIA
- BCL-2 Family Inhibitors Enhance Histone Deacetylase Inhibitor and Sorafenib Lethality via Autophagy and Overcome Blockade of the Extrinsic Pathway to Facilitate Killing
- (2009) A. P. Martin et al. MOLECULAR PHARMACOLOGY
- Induction of autophagy by B cell antigen receptor stimulation and its inhibition by costimulation
- (2008) Kozo Watanabe et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma
- (2008) J. Dal Col et al. BLOOD
- Involvement of Protective Autophagy in TRAIL Resistance of Apoptosis-defective Tumor Cells
- (2008) Jie Han et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells
- (2008) B. D. Bell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Autophagy induced by suberoylanilide hydroxamic acid in Hela S3 cells involves inhibition of protein kinase B and up-regulation of Beclin 1
- (2007) Qi Cao et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis
- (2007) Kirsteen H. Maclean et al. JOURNAL OF CLINICAL INVESTIGATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started